Breast cancer adjuvant radiotherapy in BRCA1/2, TP53, ATM genes mutations: are there solved issues?

G Lazzari, G Buono, B Zannino… - Breast Cancer: Targets …, 2021 - Taylor & Francis
BRCA1, BRCA2, TP53 and ATM gene mutations are the most studied tumour suppressor
genes (TSGs) influencing the loco-regional approach to breast cancer (BC). Due to altered …

Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation

FH Menko, K Monkhorst, FBL Hogervorst… - Critical Reviews in …, 2022 - Elsevier
Current methods of next generation sequencing may simultaneously detect multiple
germline breast cancer susceptibility variants. However, it is a challenge to maximize the …

Clinicopathologic profile of breast cancer in germline ATM and CHEK2 mutation carriers

A Toss, E Tenedini, C Piombino, M Venturelli, I Marchi… - Genes, 2021 - mdpi.com
The most common breast cancer (BC) susceptibility genes beyond BRCA1/2 are ATM and
CHEK2. For the purpose of exploring the clinicopathologic characteristics of BC developed …

Universal germline-genetic testing for breast cancer: Implementation in a rural practice and impact on shared decision-making

C Shelton, A Ruiz, L Shelton, H Montgomery… - Annals of Surgical …, 2024 - Springer
Abstract Background Whereas the National Comprehensive Cancer Network (NCCN)
criteria restrict germline-genetic testing (GGT) to a subset of breast cancer (BC) patients, the …

Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease

JQ Zhang, CH Dos Anjos, V Sevilimedu… - Annals of Surgical …, 2023 - Springer
Background The impact of ATM, CHEK2, and PALB2, the three most prevalent moderate-risk
breast cancer genes, on surgical decision making is not well known. Methods Our …

MRI-Conditional Breast Tissue Expander: First In-Human Multi-Case Assessment of MRI-Related Complications and Image Quality

S Schiaffino, A Cozzi, B Pompei, AL Scarano… - Journal of Clinical …, 2023 - mdpi.com
This study aims to assess potential complications and effects on the magnetic resonance
imaging (MRI) image quality of a new MRI-conditional breast tissue expander (Motiva …

Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy

H Huang, T Wei, A Zhang, H Zhang, L Kong, Y Li… - Clinical Breast …, 2023 - Elsevier
Background Contralateral prophylactic mastectomy (CPM) has been performed for several
decades in patients with unilateral breast cancer (BC). However, the survival benefits of …

Treatment strategies and survival outcomes in breast cancer

KL Cheung - Cancers, 2020 - mdpi.com
Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality
approach, depending on the stage and biology of the tumour and the acceptance and …

Breast conserving therapy for central breast cancer in the United States

J Liu, X Zheng, S Lin, H Han, C Xu - BMC surgery, 2022 - Springer
Introduction Although central breast cancer is not a contraindication to breast conserving,
most surgeons still choose to perform total mastectomy. The safety of breast conserving …

Influential factors on risk-reduction mastectomy in a high-risk breast cancer population with genetic predispositions

G Wei, A Kumar, MC Lee, X Wang - Clinical Breast Cancer, 2021 - Elsevier
Background Carriers of deleterious mutations in breast cancer predisposition genes are
presented with critical choices regarding cancer risk management. Risk-reduction …